Screener
TG Therapeutics TGTX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from TG Therapeutics’s reported figures.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
FAQ
- What is TG Therapeutics's enterprise value?
- TG Therapeutics (TGTX) reported enterprise value of $8.68B in Q2 2026.
- How has TG Therapeutics's enterprise value changed year-over-year?
- TG Therapeutics's enterprise value increased by 43.6% year-over-year, from $6.05B to $8.68B.
- What is the long-term trend for TG Therapeutics's enterprise value?
- Over 5 years (2020 to 2025), TG Therapeutics's enterprise value has grown at a -6.7% compound annual growth rate (CAGR), from $6.92B to $4.91B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about TG Therapeutics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude